Data / Form D filings / Pear Therapeutics, Inc.
Pear Therapeutics, Inc.: Form D filings
Pear Therapeutics, Inc., a health care company in Boston, MA, filed 5 Form D notices with the SEC between 2016 and 2021. The latest, on March 2, 2021, reports $132 million sold of a $132 million offering to 22 investors.
Find out what Pear Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 STATE STREET, 13TH FLOOR, Boston, MA, 02109
- Phone
- (646) 932-2774
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1615898
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2021 | Amendment | $131,999,923 | $131,999,923 | $0 | 22 | Dec 7, 2020 | sec.gov |
| Dec 18, 2020 | New notice | $111,999,925 | $111,999,925 | $0 | 20 | Dec 7, 2020 | sec.gov |
| Jan 4, 2019 | New notice | $64,999,912 | $64,344,915 | $654,997 | 21 | Dec 21, 2018 | sec.gov |
| Jan 12, 2018 | New notice | $50,999,997 | $45,999,998 | $4,999,999 | 14 | Dec 28, 2017 | sec.gov |
| Feb 9, 2016 | New notice | $20,422,072 | $12,422,071 | $8,000,001 | 13 | Jan 26, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Schwab | Director | |
| Elena Viboch | Director | |
| Nancy Schlichting | Director | |
| Christopher Guiffre | Executive Officer | |
| Julia Strandberg | Executive Officer | |
| Yuri Maricich | Executive Officer | |
| Ronan O'Brien | Executive Officer | |
| Corey McCann | Executive Officer, Director | |
| Zack Lynch | Director | |
| Timothy Petersen | Director |
Other health care companies in Massachusetts that filed recently
- XRHealth, Inc. $3.9 million · Oct 23, 2026
- Fresenius Medical Care Fulshear, LLC $4.4 million · Oct 21, 2026
- Nocturnal Inc. $1.9 million · Oct 20, 2026
- Mikri Inc. $1.4 million · Oct 19, 2026
- Soterya, Inc. $850,000 · Oct 13, 2026
- ArthroMeda, Inc. $8.7 million · Oct 13, 2026
- REVBIO, INC. $15 million · Oct 2, 2026
- Fresenius Medical Care Will Clayton, LLC $3.8 million · Sep 21, 2026
- DynamiCare Health, Inc. $720,000 · Sep 10, 2026
- OnPoint Surgical, Inc. $18 million · Sep 1, 2026
Every Form D from the week of Mar 1, 2021 · All recent filings in Massachusetts · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Pear Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.